| Restraint stress increases hemichannel activity in hippocampal glial cells and neurons JA Orellana, R Moraga-Amaro, R Díaz-Galarce, S Rojas, CJ Maturana, ... Frontiers in cellular neuroscience 9, 102, 2015 | 97 | 2015 |
| Interactions of pannexin 1 with NMDA and P2X7 receptors in central nervous system pathologies: Possible role on chronic pain D Bravo, CJ Maturana, T Pelissier, A Hernandez, L Constandil Pharmacological research 101, 86-93, 2015 | 72 | 2015 |
| Cannabinoids prevent the amyloid β‐induced activation of astroglial hemichannels: A neuroprotective mechanism R Gajardo‐Gómez, VC Labra, CJ Maturana, KF Shoji, CA Santibanez, ... Glia 65 (1), 122-137, 2017 | 59 | 2017 |
| High glucocorticoid levels during gestation activate the inflammasome in hippocampal oligodendrocytes of the offspring CJ Maturana, A Aguirre, JC Saez Developmental neurobiology 77 (5), 625-642, 2017 | 47 | 2017 |
| Heavy alcohol exposure activates astroglial hemichannels and pannexons in the hippocampus of adolescent rats: effects on neuroinflammation and astrocyte arborization GI Gomez, RV Falcon, CJ Maturana, VC Labra, N Salgado, CA Rojas, ... Frontiers in cellular neuroscience 12, 472, 2018 | 46 | 2018 |
| Possible involvement of TLRs and hemichannels in stress-induced CNS dysfunction via mastocytes, and glia activation A Aguirre, CJ Maturana, PA Harcha, JC Sáez Mediators of Inflammation 2013, 2013 | 43 | 2013 |
| Astroglial Ca2+-Dependent Hyperexcitability Requires P2Y1 Purinergic Receptors and Pannexin-1 Channel Activation in a Chronic Model of Epilepsy M Wellmann, C Álvarez-Ferradas, CJ Maturana, JC Sáez, C Bonansco Frontiers in Cellular Neuroscience 12, 446, 2018 | 35 | 2018 |
| Novel tool to quantify with single-cell resolution the number of incoming AAV genomes co-expressed in the mouse nervous system CJ Maturana, JL Verpeut, M Kooshkbaghi, EA Engel Gene therapy 30 (5), 463-468, 2023 | 17 | 2023 |
| Small alphaherpesvirus latency-associated promoters drive efficient and long-term transgene expression in the CNS CJ Maturana, JL Verpeut, TJ Pisano, ZM Dhanerawala, A Esteves, ... Molecular Therapy Methods & Clinical Development 17, 843-857, 2020 | 15 | 2020 |
| NMDA and P2X7 receptors require Pannexin 1 activation to initiate and maintain nociceptive signaling in the spinal cord of neuropathic rats D Bravo, K Zepeda-Morales, CJ Maturana, JS Retamal, A Hernández, ... International Journal of Molecular Sciences 23 (12), 6705, 2022 | 9 | 2022 |
| Optimized formulation buffer preserves adeno-associated virus-9 infectivity after 4 C storage and freeze/thawing cycling A Chan, CJ Maturana, EA Engel Journal of virological methods 309, 114598, 2022 | 7 | 2022 |
| Mouse footpad inoculation model to study viral-induced neuroinflammatory responses K Laval, CJ Maturana, LW Enquist JoVE (Journal of Visualized Experiments), e61121, 2020 | 6 | 2020 |
| Local and systemic administration of AAV vectors with alphaherpesvirus latency-associated promoter 2 drives potent transgene expression in mouse liver, kidney, and skeletal muscle CJ Maturana, A Chan, JL Verpeut, EA Engel Journal of Virological Methods 314, 114688, 2023 | 4 | 2023 |
| Single‐Cell Quantification of Triple‐AAV Vector Genomes Coexpressed in Neurons CJ Maturana, JL Verpeut, EA Engel Current Protocols 2 (5), e430, 2022 | 4 | 2022 |
| Engineered compact pan-neuronal promoter from Alphaherpesvirus LAP2 enhances target gene expression in the mouse brain and reduces tropism in the liver CJ Maturana Gene Therapy, 1-10, 2023 | 1 | 2023 |
| Self-complementary AAV vectors carrying dominant negative RhoA and methods of use to treat ocular diseases T Borras, G Hong, B Liang, L Wu, C Maturana US Patent App. 18/468,299, 2024 | | 2024 |
| Persistent transgene expression in peripheral tissues one year post intravenous and intramuscular administration of AAV vectors containing the alphaherpesvirus latency … CJ Maturana, EA Engel Frontiers in Virology 4, 1379991, 2024 | | 2024 |
| The Alphaherpesvirus Latency Associated Promoter (LAP2) Drives Widespread Gene Expression in Peripheral Organs Dependent on AAV Serotype and Administration Route CJ Maturana MOLECULAR THERAPY 30 (4), 236-236, 2022 | | 2022 |
| Recombinant nucleic acids containing alphaherpesvirus promoter sequences E Engel, C Maturana, L Enquist | | 2020 |
| Small Alphaherpesvirus Latency-Associated Promoters Drive Efficient and Long-Term Transgene Expression in The Central Nervous System after systemic AAV administration EA Engel, CJ Maturana, JL Verpeut, TJ Pisano, ZM Dhanarawala, ... MOLECULAR THERAPY 28 (4), 76-76, 2020 | | 2020 |
